This topic contains a solution. Click here to go to the answer

Author Question: The low-priority alarms on the BiPAP Synchrony include which of the following? a. Low battery c. ... (Read 33 times)

tth

  • Hero Member
  • *****
  • Posts: 579
The low-priority alarms on the BiPAP Synchrony include which of the following?
 
  a. Low battery c. Battery voltage too high
  b. Patient disconnect d. Momentary loss of power

Question 2

The apnea alarm on the Newport HT50 ventilator is triggered after how much time?
 
  a. Operator-selected value c. Ventilator set at 20 seconds
  b. Ventilator set at 15 seconds d. Ventilator set at 30 seconds



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

adf223

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANS: D
Momentary loss of power is a low or yellow/constant alarm on the BiPAP Synchrony. Low battery is a medium-priority alarm (yellow flashing). Patient disconnect is a high-priority, red, flashing alarm. Battery voltage too high is a medium-priority (yellow flashing) alarm.

Answer to Question 2

ANS: D
When a patient breath goes undetected for 30 seconds, an apnea alarm occurs.




tth

  • Member
  • Posts: 579
Reply 2 on: Jul 16, 2018
:D TYSM


bigcheese9

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

For a complete list of videos, visit our video library